Literature DB >> 5563402

Inhibition of gastric secretion in man by prostaglandin A.

D E Wilson, C Phillips, R A Levine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5563402

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  30 in total

Review 1.  The role of prostaglandins in gastric mucosal protection.

Authors:  D E Wilson
Journal:  Trans Am Clin Climatol Assoc       Date:  1996

Review 2.  Gastrointestinal cytoprotection by prostaglandins.

Authors:  T A Miller; E D Jacobson
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

3.  The effect of 15(R)-15-methyl prostaglandin E2 on meal-stimulated gastric acid secretion, serum gastrin, and pancreatic polypeptide in duodenal ulcer patients.

Authors:  W Peterson; M Feldman; I Taylor; M Bremer
Journal:  Dig Dis Sci       Date:  1979-05       Impact factor: 3.199

Review 4.  Medical management of peptic ulcer with reference to anti-ulcer agents in other gastro-intestinal diseases.

Authors:  D W Piper; T R Heap
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 5.  Prostaglandins and the gastrointestinal tract.

Authors:  S L Waller
Journal:  Gut       Date:  1973-05       Impact factor: 23.059

6.  The effects of a prostaglandin endoperoxide analogue on canine gastric acid and mucus secretion.

Authors:  P Tao; W Scruggs; D E Wilson
Journal:  Dig Dis Sci       Date:  1979-06       Impact factor: 3.199

7.  Activation of human large bowel adenylate cyclase by methylated prostaglandin E2 analogues.

Authors:  B Simon; K R Koczorek; H Kather
Journal:  Klin Wochenschr       Date:  1979-04-17

8.  Immunocytochemical studies on the localization of pancreatic-type phospholipase A2 in rat stomach and pancreas, with special reference to the stomach cells.

Authors:  H Tasumi; H Tojo; T Senda; T Ono; H Fujita; M Okamoto
Journal:  Histochemistry       Date:  1990

9.  Prostaglandins in peptic ulcer disease. An overview of current status and future directions.

Authors:  S J Sontag
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

10.  Non-steroidal anti-inflammatory drugs and peptic ulcer perforation.

Authors:  D S Collier; J A Pain
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.